Sami L Gottlieb

TL;DR: Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day.

TL;DR: The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.

TL;DR: In this paper, a review summarizes current approaches to diagnosis and treatment and the future prospects for better prevention strategies for pelvic inflammatory disease, which can produce acute symptoms and result in infertility, ectopic pregnancy and chronic pelvic pain.

TL;DR: Genital HSV-1 burden can be substantial but varies widely by region, and future control efforts, including development of HSV vaccines, should consider the epidemiology of HSv-1 in addition toHSV-2, and especially the relative contribution of HS V-1 to genital infection.

TL;DR: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSv-2 to partners or neonates, highlighting the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.